Stabilization of a polypeptide in non-aqueous solvents

被引:6
|
作者
Wang, Wei [1 ]
Martin-Moe, Sheryl [1 ]
Pan, Clark [1 ]
Musza, Laszlo [1 ]
Wang, Y. John [1 ]
机构
[1] Bayer Healthcare, Berkeley, CA 94701 USA
关键词
peptide stability; non-aqueous solvent; deamidation; zinc stabilization; dimerization; PACAP;
D O I
10.1016/j.ijpharm.2007.09.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A pituitary adenylate cyclase-activating peptide (PACAP) analogue (HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY, P66) was formulated in several non-aqueous solvents in anticipation of improved shelf-life stability. However, the stability of this peptide in these solvents was found to be as poor as in an aqueous solution. The major degradation reaction in non-aqueous solvents was dimer formation. The proposed mechanism for dimerization was a nucleophilic attack of a basic amino acid on cyclic imide formed by dehydration or deamidation of Asp or Asn. Two approaches were found to be effective in stabilizing the peptide in non-aqueous solvents: (1) acidification of the peptide and (2) use of zinc chloride in the formulation. Stabilization could be attributed to reduction of the nucleophilicity of the reactive groups through protonation and metal-peptide interaction through chelation. The stabilization approaches are applicable only in a non-aqueous environment for this peptide, and possibly for other peptides with similar reactive moieties. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条